EverPoint Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

EverPoint Asset Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$7.16M	Buy	+460,000	New	+$7.64M	0.13%	181

Other funds holding COLL

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

EverPoint Asset Management's COLL Position: Q4 2016 in Review

EverPoint Asset Management opened a new position in Collegium Pharmaceutical (COLL) in Q4 2016: 460,000 shares worth $7.16M. The stake represents 0.13% of the portfolio and ranks #181 among its holdings.

88 funds tracked by Wall St. Rank hold COLL as of Q4 2016.

EverPoint Asset Management held 460,000 shares of Collegium Pharmaceutical worth $7.16M as of Q4 2016.
Collegium Pharmaceutical was a new EverPoint Asset Management position in Q4 2016.
Collegium Pharmaceutical made up 0.13% of EverPoint Asset Management's portfolio in Q4 2016, its #181 holding.
88 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.